Getinge Interim Report January-March 2016

First quarter of 2016 in brief 

  • Order intake declined by 3.7% to SEK 6,924 M (7,192). The order intake declined organically by 2.0%.
  • Net sales fell by 5.0% to SEK 6,377 M (6,712). Net sales fell organically by 3.2%.
  • The gross margin increased to 47.2% (46.8).
  • EBITA* fell by 13.5% to SEK 620 M (717).
  • Restructuring and integration costs amounted to SEK 127 M (183).
  • Profit before tax amounted to SEK 157 M (146), corresponding to an increase of 7.5%.
  • Earnings per share amounted to SEK 0.46 (0.38).
  • Good cost control – adjusted for exchange-rate effects, administrative and selling expenses declined by 4.4%.
  • Cash conversion from operating activities amounted to 75.5% (69.8).
  • The transformation program is progressing according to plan and efficiency initiatives are starting to generate results.
  • New reporting structure for the Group with three new reporting segments based on the three Business Category Units Surgical Workflows, Acute Care Therapies and Patient & Post-Acute Care.

FINANCIAL SUMMARY

MSEK Jan-Mar 2016 Jan-Mar 2015 Change % Rolling 12M FY 2015
Order intake 6 924 7 192 -3.7% 30 163 30 431
Net sales 6 377 6 712 -5.0% 29 900 30 235
Gross Profit 3 011 3 142 -4.2% 14 032 14 163
Gross margin 47.2% 46.8% 0.4% 46.9% 46.8%
EBITA* 620 717 -13.5% 4 082 4 179
EBITA margin* 9.7% 10.7% -1.0% 13.7% 13.8%
Operating profit 316 335 -5.7% 2 710 2 729
Profit before tax 157 146 7.5% 2 008 1 997
Net profit 115 107 7.5% 1 465 1 457
Earnings per share, SEK                      0.46                  0.38   21.1%                5.91                5.83  
Cash flow from operations                      700                    654 7.0%                  3 504                3 458

* before restructuring, acquisition and integration cost

Tags:

About Us

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.

Subscribe

Documents & Links